Stay updated with breaking news from Rectal Gel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WARREN, N.J., April 12, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company” or “Aquestive”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through
Reiterates commencement of pivotal pharmacokinetic (PK) study for Anaphylm™ (epinephrine) Sublingual Film expected in fourth quarter 2023 with topline data...
Mumbai, Baltimore, November 02, 2023: Global pharma major Lupin Limited today announced the launch of Diazepam Rectal Gel, 10 mg and 20 mg, Rectal Delivery System, after its wholly...
Mumbai, Baltimore, June01, 2023: Global pharma major Lupin Limited today announced that its wholly-owned subsidiary, Novel Laboratories Inc., based in Somerset, New Jersey, has... | June 1, 2023
Lupin Limited's subsidiary, Novel Laboratories Inc., based in Somerset, New Jersey, has received approval from the U.S. FDA for its Abbreviated New Drug Application for Diazepam Rectal Gel, 10 mg and 20 mg, Rectal Delivery System.